Literature DB >> 3742454

Cell proliferation and DNA content in non-Hodgkin's lymphoma. Flow cytometry in relation to lymphoma classification.

B Christensson, B Tribukait, I L Linder, B Ullman, P Biberfeld.   

Abstract

Flow cytofluorometric (FCF) DNA analysis was performed on specimens from 154 patients with non-Hodgkin's lymphoma (NHL) and correlated to histopathology according to the Rappaport classification and the Working Formulation of NHL for clinical usage (WF). NHL associated with unfavorable prognosis (UP) had significantly higher proportions of cells in S-phase as compared to the favorable prognosis (FP) group. The proportion of S-phase cells also differed significantly between the low-, intermediate-, and high-grade malignancy groups of the WF. Aneuploidy was significantly more frequent in the UP (41%) than in the FP (15%) group. By stepwise discriminant analysis, the S-phase frequency was a stronger discriminator between prognostic groups than DNA content. Classification by discriminant analysis showed that over 90% of the low grade/FP lymphomas were allocated to the good prognosis group by their S-phase and DNA values. Due to the variation in the proportion of S-phase cells in the intermediate grade and high grade, as well as the UP lymphomas, only approximately 50% of the UP and 60% of the high-grade lymphomas were identified as such by this discriminant model, while almost one half of the intermediate-grade lymphomas were allocated to the low-grade group. The results suggest that S-phase analysis can be of value in distinguishing intermediate- and high-grade lymphomas with high and low proportions of proliferating cells, which may be prognostic importance.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3742454     DOI: 10.1002/1097-0142(19860915)58:6<1295::aid-cncr2820580620>3.0.co;2-h

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  14 in total

1.  DNA quantitation of Wilms' tumour (nephroblastoma) using flow cytometry and image analysis.

Authors:  S Gururangan; A Dorman; R Ball; B Curran; M Leader; F Breatnach; A O'Meara
Journal:  J Clin Pathol       Date:  1992-06       Impact factor: 3.411

2.  DNA flow cytometry of follicular non-Hodgkin's lymphoma.

Authors:  J C Macartney; R S Camplejohn; R Morris; K Hollowood; D Clarke; A Timothy
Journal:  J Clin Pathol       Date:  1991-03       Impact factor: 3.411

3.  Cell proliferation in non-Hodgkin's lymphomas. Digital image analysis of Ki-67 antibody staining.

Authors:  B R Schwartz; G Pinkus; S Bacus; M Toder; D S Weinberg
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

4.  Prognostic indicators in centroblastic-centrocytic lymphoma.

Authors:  N R Griffin; M R Howard; P Quirke; C J O'Brien; J A Child; C C Bird
Journal:  J Clin Pathol       Date:  1988-08       Impact factor: 3.411

5.  The role of cell cycle activity in the generation of morphologic heterogeneity in non-Hodgkin's lymphoma.

Authors:  D S Weinberg
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

6.  Quantity of nuclear DNA in malignancies and benign lymphadenopathies associated with Epstein-Barr virus.

Authors:  T Lehtinen; M Lehtinen; R Aine; K Dammert; P Kulomaa; M Alavaikko; P Leinikki
Journal:  J Clin Pathol       Date:  1989-07       Impact factor: 3.411

7.  Diagnostic and prognostic values of S-phase fraction and aneuploidy in patients with bone marrow aplasia.

Authors:  Payal Tripathi; Anil Kumar Tripathi; Ashutosh Kumar; Rizwan Ahmad; Anil Kumar Balapure; Achchhe Lal Vishwakerma
Journal:  Indian J Hematol Blood Transfus       Date:  2009-04-06       Impact factor: 0.900

8.  Flow-cytometric DNA content of histiocytosis X (Langerhans cell histiocytosis).

Authors:  M S Rabkin; C T Wittwer; C R Kjeldsberg; M W Piepkorn
Journal:  Am J Pathol       Date:  1988-05       Impact factor: 4.307

9.  DNA content of T-cell lymphomas. A flow-cytometric analysis.

Authors:  D A Egerter; J W Said; S Epling; S Lee
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

10.  Tanzanian malignant lymphomas: WHO classification, presentation, ploidy, proliferation and HIV/EBV association.

Authors:  Amos R Mwakigonja; Ephata E Kaaya; Thomas Heiden; German Wannhoff; Juan Castro; Fatemeh Pak; Anna Porwit; Peter Biberfeld
Journal:  BMC Cancer       Date:  2010-07-01       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.